Tricyclic antidepressants for autism spectrum disorders (ASD) in children and adolescents-Reference-Cited by-同舟云学术

Tricyclic antidepressants for autism spectrum disorders (ASD) in children and adolescents

Published:2012-03-14 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Hurwitz Romy¹,Blackmore Roger¹,Hazell Philip²,Williams Katrina³,Woolfenden Susan⁴

Affiliation:

1. Sydney South West Local Health District, Liverpool Hospital; Department of Community Paediatrics; Hugh Jardine Building Locked Bag 7017 Liverpool BC NSW Australia 1871

2. Sydney Medical School; Discipline of Psychiatry; G03 - Thomas Walker Hospital Hospital Rd Concord West New South Wales Australia 2138

3. Royal Children's Hospital; Department of Developmental Medicine; Flemington Rd Parkville Victoria Australia 3052

4. Sydney Children's Community Health Centre; Sydney Children's Hospitals Network; cnr Avoca and Barker St Randwick NSW Australia 2031

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD008372.pub2/fullpdf

Reference45 articles.

1. A double-blind comparison of clomipramine, desipramine and placebo in the treatment of Autistic Disorder;Gordon;Archives of General Psychiatry,1993

2. Tianeptine: A novel strategy of psychopharmacological treatment of children with autistic disorder;Niederhofer;Human Psychopharmacology,2003

3. Clomipramine versus haloperidol in the treatment of autistic disorder: a double-blind, placebo-controlled, crossover study;Remington;Journal of Clinical Psychopharmacology,2001

4. Preliminary study of imipramine in profoundly retarded residents;Aman;Journal of Autism and Developmental Disorders,1986

5. Clomipramine ameliorates adventitious movements and compulsions in prepubertal boys with autistic disorder and severe mental retardation;Brasic;Neurology,1994

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Supplementation Therapy in Autism and Response to Treatment (START) Study: An Open-Label Feasibility Trial of Ultramicronized Palmitoylethanolamide Potential to Alleviate Psychic Distress among Autistic Adults;Clinical and Translational Neuroscience;2024-05-29

3. Autism spectrum disorder: pathogenesis, biomarker, and intervention therapy;MedComm;2024-03

4. Psychopharmacological treatments in Down syndrome and autism spectrum disorder: State of the research and practical considerations;American Journal of Medical Genetics Part C: Seminars in Medical Genetics;2023-10-23

5. Pharmacological intervention for irritability, aggression, and self-injury in autism spectrum disorder (ASD);Cochrane Database of Systematic Reviews;2023-10-09